Market Overview:
The global nucleic acid testing market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth of the market can be attributed to the increasing incidence of infectious diseases, growing demand for early diagnosis and treatment, and technological advancements in nucleic acid testing methods. The transcription-mediated amplification (TMA) segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to its high accuracy and sensitivity compared with other methods such as polymerase chain reaction (PCR) and ligase chain reaction (LCR). The hospitals segment is expected to dominate the global nucleic acid testing market in terms of revenue share during the forecast period. This can be attributed to rising demand for early diagnosis and treatment of infectious diseases in hospitals.
Product Definition:
Nucleic acid testing is the process of detecting and quantifying nucleic acids, which are the building blocks of DNA. The importance of nucleic acid testing lies in its ability to detect genetic abnormalities, viruses, and other infections.
Transcription-mediated Amplification (TMA):
Transcription-mediated amplification (TMA) is a process in which DNA is transcribed into RNA by the action of RNA polymerase. The mechanism behind this process involves the binding of transcription factors to specific sites on the DNA and then they act as initiators for nuclear transcription.
The most commonly used method for detecting TMA is called quantitative real-time PCR (qPCR). It involves two steps, i.e.
Polymerase Chain Reaction (PCR):
Polymerase chain reaction (PCR) is an important technique used in molecular diagnostics for the detection and quantification of nucleic acid. It is a key technology employed in clinical laboratories to detect and measure genetic material such as DNA & RNA. The process involves the amplification of a specific region or pattern from an original sample using a thermostable DNA polymerase enzyme.
Application Insights:
The research institutes application segment dominated the global market in 2017. This is attributed to the rising number of R&D activities being carried out using genetic markers for disease diagnosis and related studies. For instance, a research study was conducted by researchers at The University of Texas Medical Branch (UTMB) to compare whole-genome sequencing technologies for clinical care. The study found that whole-genome sequencing offers potential benefits in clinical care through reduction in cost, shorter timeframes for results, and increased accuracy as compared to other diagnostic methods such as Next-generation Sequencing (NGS).
The hospitals application segment is expected register the fastest CAGR from 2018 to 2030 owing to an increase in hospital admissions due to various diseases associated with genomic imbalance such as Cri-du-chat, hemophilia A & B, Hunter¢â‚¬â„¢s syndrome & others which involves the use of nucleic acid testing procedures for accurate diagnosis.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, high adoption rate for technologically advanced tests, and government support for quality healthcare. For instance, in 2014 FDA approved Ion Torrent’s Genome Analyzer DNA Test as a diagnostic tool to detect mutations in the BRCA1 and BRCA2 genes that are associated with an increased risk of breast cancer. Asia Pacific is expected to grow at a lucrative CAGR over the forecast period owing to increasing prevalence of genetic disorders & cancer along with growing investments by governments & private firms for developing novel testing technologies.
In addition, favorable regulatory policies regarding approval and commercialization of genomic tests will also boost revenue growth over this region.
Growth Factors:
- Increasing demand for nucleic acid testing in the field of personalized medicine
- Rising prevalence of infectious diseases and genetic disorders
- Technological advancements in nucleic acid testing platforms and assay kits
- Growing number of public-private partnerships for development of novel nucleic acid tests
- Increasing awareness about the benefits of early diagnosis through nucleic acid testing
Scope Of The Report
Report Attributes
Report Details
Report Title
Nucleic Acid Testing Market Research Report
By Type
Transcription-mediated Amplification (TMA), Polymerase Chain Reaction (PCR), Ligase Chain Reaction (LCR), Whole Genome Sequencing
By Application
Hospitals, Pathology Laboratories, Research Institutes, Clinics
By Companies
Agilent Technologies, Danaher Corporation, Abbott Laboratories, Inc., Becton, Dickinson, Bio-Rad Laboratories, Roche, Illumina, Inc, Thermo Fisher Scientific Inc., Merck KGaA, Qiagen
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
158
Number of Tables & Figures
111
Customization Available
Yes, the report can be customized as per your need.
Global Nucleic Acid Testing Market Report Segments:
The global Nucleic Acid Testing market is segmented on the basis of:
Types
Transcription-mediated Amplification (TMA), Polymerase Chain Reaction (PCR), Ligase Chain Reaction (LCR), Whole Genome Sequencing
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Pathology Laboratories, Research Institutes, Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Agilent Technologies
- Danaher Corporation
- Abbott Laboratories, Inc.
- Becton, Dickinson
- Bio-Rad Laboratories
- Roche
- Illumina, Inc
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Qiagen
Highlights of The Nucleic Acid Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Transcription-mediated Amplification (TMA)
- Polymerase Chain Reaction (PCR)
- Ligase Chain Reaction (LCR)
- Whole Genome Sequencing
- By Application:
- Hospitals
- Pathology Laboratories
- Research Institutes
- Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nucleic Acid Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Nucleic acid testing is a laboratory test that uses nucleic acids, such as DNA or RNA, to identify the presence of a specific gene or genetic sequence. This test can be used to diagnose certain medical conditions and to monitor the health of patients.
Some of the major players in the nucleic acid testing market are Agilent Technologies, Danaher Corporation, Abbott Laboratories, Inc., Becton, Dickinson, Bio-Rad Laboratories, Roche, Illumina, Inc, Thermo Fisher Scientific Inc., Merck KGaA, Qiagen.
The nucleic acid testing market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Nucleic Acid Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Nucleic Acid Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Nucleic Acid Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Nucleic Acid Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Nucleic Acid Testing Market Size & Forecast, 2020-2028
4.5.1 Nucleic Acid Testing Market Size and Y-o-Y Growth
4.5.2 Nucleic Acid Testing Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Transcription-mediated Amplification (TMA)
5.2.2 Polymerase Chain Reaction (PCR)
5.2.3 Ligase Chain Reaction (LCR)
5.2.4 Whole Genome Sequencing
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Pathology Laboratories
6.2.3 Research Institutes
6.2.4 Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Nucleic Acid Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Nucleic Acid Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Transcription-mediated Amplification (TMA)
9.6.2 Polymerase Chain Reaction (PCR)
9.6.3 Ligase Chain Reaction (LCR)
9.6.4 Whole Genome Sequencing
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Pathology Laboratories
9.10.3 Research Institutes
9.10.4 Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Transcription-mediated Amplification (TMA)
10.6.2 Polymerase Chain Reaction (PCR)
10.6.3 Ligase Chain Reaction (LCR)
10.6.4 Whole Genome Sequencing
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Pathology Laboratories
10.10.3 Research Institutes
10.10.4 Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Transcription-mediated Amplification (TMA)
11.6.2 Polymerase Chain Reaction (PCR)
11.6.3 Ligase Chain Reaction (LCR)
11.6.4 Whole Genome Sequencing
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Pathology Laboratories
11.10.3 Research Institutes
11.10.4 Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Transcription-mediated Amplification (TMA)
12.6.2 Polymerase Chain Reaction (PCR)
12.6.3 Ligase Chain Reaction (LCR)
12.6.4 Whole Genome Sequencing
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Pathology Laboratories
12.10.3 Research Institutes
12.10.4 Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Transcription-mediated Amplification (TMA)
13.6.2 Polymerase Chain Reaction (PCR)
13.6.3 Ligase Chain Reaction (LCR)
13.6.4 Whole Genome Sequencing
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Pathology Laboratories
13.10.3 Research Institutes
13.10.4 Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Nucleic Acid Testing Market: Competitive Dashboard
14.2 Global Nucleic Acid Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Agilent Technologies
14.3.2 Danaher Corporation
14.3.3 Abbott Laboratories, Inc.
14.3.4 Becton, Dickinson
14.3.5 Bio-Rad Laboratories
14.3.6 Roche
14.3.7 Illumina, Inc
14.3.8 Thermo Fisher Scientific Inc.
14.3.9 Merck KGaA
14.3.10 Qiagen
